“Do We Want Science to Reinvent Human Aging?”
By Bill McKibben and Gregory Stock,
Transcript of live debate
| 03. 27. 2003
Daniel Perry, Executive Director, Alliance for Aging Research:
Good afternoon, my name is Dan Perry and I’m the Executive
Director of the not-for-profit Alliance for Aging Research.
It gives me great pleasure to welcome you to the second debate
under the banner of SAGE Crossroads. This is a project that
will continue for the next three years, bringing to light the
crosscurrents in our political life that affect the science
of aging. We know that there is a great deal of research going
on in the United States and around the world trying to plum
the secrets of human aging, and as it increasingly becomes possible
to modify the trajectory of human aging there will certainly
be consequences, indeed controversies, that go to our economics,
our politics, our religion and our sense of ourselves as human
beings.
Today’s debate is one that really brings focus very sharply
on this question, as we will soon hear from our two esteemed
participants, Doctor Gregory Stock, who is the director of UCLA’s
Program on Medicine, Technology and Society, and a widely quoted
lecturer...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Jay S. Kaufman, Los Angeles Review of Books | 09.27.2025
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...